Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms. - Watts J; Minden MD; Bachiashvili K; Brunner AM; Abedin S; Crossman T; Zajac M; Moroz V; Egger JL; Tarkar A; Kremer BE; Barbash O; et al. (Therapeutic advances in hematology, 2024)